中国儿童呼吸道合胞病毒疾病负担及流行趋势研究进展
Research Progress on Disease Burden and Epidemiological Trends of Respiratory Syncytial Virus Infection in Chinese Children
DOI: 10.12677/acm.2026.1641683, PDF,   
作者: 叶又铭*, 刘恩梅#:重庆医科大学附属儿童医院呼吸科,儿童少年健康与疾病国家临床医学研究中心,儿童发育疾病研究教育部重点实验室,儿童感染与免疫罕见病重庆市重点实验室,重庆
关键词: 呼吸道合胞病毒儿童疾病负担流行病学Respiratory Syncytial Virus Children Disease Burden Epidemiology
摘要: 呼吸道合胞病毒(Respiratory Syncytial Virus, RSV)是我国5岁以下儿童急性呼吸道感染的首要病原体,带来显著疾病负担,还会增加儿童后续喘息、哮喘等长期健康风险。2020年起,我国儿童RSV流行特征出现显著变化,其中2023年RSV感染易感年龄后移、流行季节规律被打破,混合感染率上升且肺炎支原体为主要共感染病原,加剧诊疗难度。本文对中国儿童RSV疾病负担及流行趋势进行综述,为免疫防控提供参考。
Abstract: Respiratory syncytial virus (RSV) is the leading pathogen causing acute respiratory infections among children under 5 years old in China. It imposes a substantial disease burden and increases the long-term health risks of subsequent wheezing and asthma in children. Since 2020, RSV epidemiological characteristics in Chinese children have changed significantly. In 2023, the susceptible age shifted older, seasonal patterns were disrupted, co-infection rates increased with Mycoplasma pneumoniae as the predominant pathogen, complicating diagnosis and treatment. This paper reviews the disease burden and epidemiological trends of RSV in Chinese children, providing a reference for immune prevention and control.
文章引用:叶又铭, 刘恩梅. 中国儿童呼吸道合胞病毒疾病负担及流行趋势研究进展[J]. 临床医学进展, 2026, 16(4): 4142-4149. https://doi.org/10.12677/acm.2026.1641683

参考文献

[1] Rosas-Salazar, C., Chirkova, T., Gebretsadik, T., Chappell, J.D., Peebles, R.S., Dupont, W.D., et al. (2023) Respiratory Syncytial Virus Infection during Infancy and Asthma during Childhood in the USA (INSPIRE): A Population-Based, Prospective Birth Cohort Study. The Lancet, 401, 1669-1680. [Google Scholar] [CrossRef] [PubMed]
[2] Li, Y., Wang, X., Blau, D.M., Caballero, M.T., Feikin, D.R., Gill, C.J., et al. (2022) Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Children Younger than 5 Years in 2019: A Systematic Analysis. The Lancet, 399, 2047-2064. [Google Scholar] [CrossRef] [PubMed]
[3] Li, Y., Johnson, E.K., Shi, T., Campbell, H., Chaves, S.S., Commaille-Chapus, C., et al. (2021) National Burden Estimates of Hospitalisations for Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Young Children in 2019 among 58 Countries: A Modelling Study. The Lancet Respiratory Medicine, 9, 175-185. [Google Scholar] [CrossRef] [PubMed]
[4] Kirolos, N., Mtaweh, H., Datta, R.R., Farrar, D.S., Seaton, C., Bone, J.N., et al. (2025) Risk Factors for Severe Disease among Children Hospitalized with Respiratory Syncytial Virus. JAMA Network Open, 8, e254666. [Google Scholar] [CrossRef] [PubMed]
[5] Shang, Z., Tan, S. and Ma, D. (2021) Respiratory Syncytial Virus: From Pathogenesis to Potential Therapeutic Strategies. International Journal of Biological Sciences, 17, 4073-4091. [Google Scholar] [CrossRef] [PubMed]
[6] McLellan, J.S., Chen, M., Joyce, M.G., Sastry, M., Stewart-Jones, G.B.E., Yang, Y., et al. (2013) Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus. Science, 342, 592-598. [Google Scholar] [CrossRef] [PubMed]
[7] Anderson, L., Jadhao, S., Paden, C. and Tong, S. (2021) Functional Features of the Respiratory Syncytial Virus G Protein. Viruses, 13, Article 1214. [Google Scholar] [CrossRef] [PubMed]
[8] Li, Z.J., Zhang, H.Y., Ren, L.L., et al. (2021) Etiological and Epidemiological Features of Acute Respiratory Infections in China. Nature Communications, 12, Article No. 5026.
[9] Duan, Y., Jiang, M., Huang, Q., Jia, M., Yang, W. and Feng, L. (2023) Incidence, Hospitalization, and Mortality in Children Aged 5 Years and Younger with Respiratory Syncytial Virus‐Related Diseases: A Systematic Review and Meta‐Analysis. Influenza and Other Respiratory Viruses, 17, e13145. [Google Scholar] [CrossRef] [PubMed]
[10] 崔爱利, 夏百成, 朱贞, 等. 2009-2023年中国16个省份急性呼吸道感染病例中人呼吸道合胞病毒的流行特征分析[J]. 中华预防医学杂志, 2024, 58(7): 945-951.
[11] Jiang, M., Sun, Q., Qiu, X., Mei, Q., Tu, Y., Wang, F., et al. (2026) Multi-Dimensional Epidemiology of Pediatric Acute Respiratory Tract Infection in Ningbo, China (2020-2024): Age-Specific Susceptibility, Pathogen Dynamics, and Epidemiological Trends. Frontiers in Cellular and Infection Microbiology, 16, Article ID: 1662777. [Google Scholar] [CrossRef
[12] Li, K., Hamrin, J., Nilsson, A., Weinberger, D.M. and Pitzer, V.E. (2025) Unraveling the Role of Viral Interference in Disrupting Biennial RSV Epidemics in Northern Stockholm. Nature Communications, 16, Article No. 8137. [Google Scholar] [CrossRef
[13] Ren, L., Cui, L., Wang, Q., Gao, L., Xu, M., Wang, M., et al. (2023) Cost and Health‐Related Quality of Life for Children Hospitalized with Respiratory Syncytial Virus in Central China. Influenza and Other Respiratory Viruses, 17, e13180. [Google Scholar] [CrossRef] [PubMed]
[14] Li, T., Fang, H., Liu, X., Deng, Y., Zang, N., Xie, J., et al. (2024) Burden of RSV among Inpatients with Lower Respiratory Tract Infection under 5 Years of Age: A 10-Year Retrospective Study in Southwest China from 2009 to 2019. Chinese Medical Journal Pulmonary and Critical Care Medicine, 2, 182-187. [Google Scholar] [CrossRef] [PubMed]
[15] Ponce, L.J., Wu, T., Sim, D.J., Chow, J.Y., Wee, L.E., Chia, P.Y., et al. (2025) Respiratory Syncytial Virus Hospitalization Costs, Rates, and Seasonality in Asia: A Systematic Review and Meta-Analysis. eClinicalMedicine, 86, Article 103350. [Google Scholar] [CrossRef] [PubMed]
[16] Shi, T., Ooi, Y., Zaw, E.M., et al. (2020) Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood. The Journal of Infectious Diseases, 222, S628-S633.
[17] McGinley, J.P., Lin, G.L., Öner, D., Golubchik, T., O’Connor, D., Snape, M.D., et al. (2022) Clinical and Viral Factors Associated with Disease Severity and Subsequent Wheezing in Infants with Respiratory Syncytial Virus Infection. The Journal of Infectious Diseases, 226, S45-S54. [Google Scholar] [CrossRef] [PubMed]
[18] van Meel, E.R., Mensink-Bout, S.M., den Dekker, H.T., Ahluwalia, T.S., Annesi-Maesano, I., Arshad, S.H., et al. (2022) Early-Life Respiratory Tract Infections and the Risk of School-Age Lower Lung Function and Asthma: A Meta-Analysis of 150 000 European Children. European Respiratory Journal, 60, Article 2102395. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, Q., Pan, Y., Gao, H., Zhao, Y., Gao, X., Da, Y., et al. (2025) Analysis of Respiratory Pathogens in Pediatric Acute Respiratory Infections in Lanzhou, Northwest China, 2019-2024. Frontiers in Cellular and Infection Microbiology, 14, Article ID: 1494166. [Google Scholar] [CrossRef] [PubMed]
[20] Tang, L., Ma, L., Liang, Y. and Chen, X. (2025) Epidemic Patterns and the Immunity Levels in Hospitalized Patients with Respiratory Syncytial Virus Infection in 2019-2023. The Journal of Infection in Developing Countries, 19, 289-297. [Google Scholar] [CrossRef] [PubMed]
[21] 刘梦杰, 陈依东, 魏瑗. 人类胎肺成熟机制研究进展[J]. 中华医学杂志, 2025, 105(3): 248-251.
[22] Wang, X., Li, Y., Shi, T., Bont, L.J., Chu, H.Y., Zar, H.J., et al. (2024) Global Disease Burden of and Risk Factors for Acute Lower Respiratory Infections Caused by Respiratory Syncytial Virus in Preterm Infants and Young Children in 2019: A Systematic Review and Meta-Analysis of Aggregated and Individual Participant Data. The Lancet, 403, 1241-1253. [Google Scholar] [CrossRef] [PubMed]
[23] 傅昌雨, 李琦, 孙弢. 2023-2024年苏州地区儿童肺炎患者常见非细菌性呼吸道病原体流行病学特征分析[J/OL].中国典型病例大全, 1-7. 2026-04-16.[CrossRef
[24] Zhao, X., Zhu, X., Wang, J., Ye, C. and Zhao, S. (2025) The Epidemiological Analysis of Respiratory Virus Infections in Children in Hangzhou from 2019 to 2023. Virus Research, 355, Article 199558. [Google Scholar] [CrossRef] [PubMed]
[25] Guo, L., Deng, S., Sun, S., Wang, X. and Li, Y. (2024) Respiratory Syncytial Virus Seasonality, Transmission Zones, and Implications for Seasonal Prevention Strategy in China: A Systematic Analysis. The Lancet Global Health, 12, e1005-e1016. [Google Scholar] [CrossRef] [PubMed]
[26] Long, S., Hu, R., Ouyang, J., Tian, C., Guo, T., Luo, Q., et al. (2025) Epidemiological Analysis of Pediatric Respiratory Pathogens in Hunan, China: A Retrospective Multicenter Study from 2022 to 2024. BMC Infectious Diseases, 26, Article No. 60. [Google Scholar] [CrossRef
[27] Song, J., Zhu, Z., Song, J., Mao, N., Cui, A., Xu, W., et al. (2023) Circulation Pattern and Genetic Variation of Human Respiratory Syncytial Virus in China during 2008-2021. Journal of Medical Virology, 95, e28611. [Google Scholar] [CrossRef] [PubMed]
[28] 黄娟, 李启亮, 李飞, 等. 2023-2025年北京地区儿童呼吸道合胞病毒感染的分子流行病学特征[J]. 中华微生物学和免疫学杂志, 2026, 46(1): 58-66.
[29] Wu, J., Jia, Y., Jiang, Y., He, F., Shi, X., Wang, X., et al. (2026) Epidemiological Characteristics and Whole-Genome Analysis of Respiratory Syncytial Virus in Jining City from February 2023 to December 2024. Frontiers in Microbiology, 17, Article ID: 1702525. [Google Scholar] [CrossRef
[30] 袁可, 牟文凤, 吕朦, 等. 2023年至2025年青岛地区5岁以下急性呼吸道感染住院患儿的呼吸道合胞病毒流行特征: 横断面研究[J]. 中华围产医学杂志, 2025, 28(12): 1035-1041.
[31] 冯建宇, 李书书, 韩树萍, 等. 早产儿呼吸道合胞病毒感染疾病负担与防治研究进展[J]. 中华围产医学杂志, 2025, 28(12): 1071-1076.
[32] Garegnani, L., Roson Rodriguez, P., Escobar Liquitay, C.M., Esteban, I. and Franco, J.V. (2025) Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Children. Cochrane Database of Systematic Reviews, No. 7, CD013757. [Google Scholar] [CrossRef] [PubMed]
[33] Simões, E.A.F., Madhi, S.A., Muller, W.J., Atanasova, V., Bosheva, M., Cabañas, F., et al. (2023) Efficacy of Nirsevimab against Respiratory Syncytial Virus Lower Respiratory Tract Infections in Preterm and Term Infants, and Pharmacokinetic Extrapolation to Infants with Congenital Heart Disease and Chronic Lung Disease: A Pooled Analysis of Randomised Controlled Trials. The Lancet Child & Adolescent Health, 7, 180-189. [Google Scholar] [CrossRef] [PubMed]
[34] 中国医药教育协会儿科专业委员会, 中华医学会儿科学分会呼吸学组哮喘协作组, 中国医师协会呼吸医师分会儿科呼吸工作委员会, 等. 中国婴儿尼塞韦单克隆抗体应用专家建议[J]. 中华实用儿科临床杂志, 2025, 40(7): 490-496.
[35] Moulia, D.L., Link-Gelles, R., Chu, H.Y., Jamieson, D., Brooks, O., Meyer, S., et al. (2025) Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices—United States, 2025. MMWR. Morbidity and Mortality Weekly Report, 74, 508-514. [Google Scholar] [CrossRef
[36] Trinomab (2025) China’s Trinomab Presents Groundbreaking Phase 2B Trial Data for Anti-RSV Antibody TNM001 in an Oral Session at IDWeek 2025.
https://www.trinomab.com/en-us/info/532.html
[37] Simões, E.A.F., Pahud, B.A., Madhi, S.A., Kampmann, B., Shittu, E., Radley, D., et al. (2025) Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial. Obstetrics & Gynecology, 145, 157-167. [Google Scholar] [CrossRef] [PubMed]
[38] Sáez-Llorens, X., Norero, X., Mussi-Pinhata, M.M., Luciani, K., de la Cueva, I.S., Díez-Domingo, J., et al. (2024) Safety and Immunogenicity of a Chad155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of Age: A Phase 1/2 Randomized Trial. The Journal of Infectious Diseases, 229, 95-107. [Google Scholar] [CrossRef] [PubMed]